Core Viewpoint - Aqua Theon, a California-based startup, has successfully raised $13 million in seed funding to expand its functional seaweed beverage brand, OoMee, targeting the growing GLP-1 market in the U.S. [6][7] Group 1: Funding and Expansion - Aqua Theon raised $13 million in seed funding, with $5 million allocated specifically for expanding the OoMee brand [6] - The funding round was led by Sparx Asset Management, with participation from Beyond Next Ventures and World Innovation Lab [6] - The company plans to use the remaining funds to develop its high-end Japanese crystal candy brand, Misaky Tokyo [6] Group 2: Product Concept and Market Positioning - OoMee is marketed as a functional beverage that helps suppress appetite and maintain satiety, aligning with the growing GLP-1 market [7] - The brand has received positive market feedback, with the founder noting a shift from skepticism to trust in seaweed beverages [7] - The product emphasizes digestive health and appetite control, avoiding a focus solely on seaweed [12] Group 3: Innovation and Technology - Aqua Theon utilizes proprietary ingredients called Seabiotics, derived from agar-agar, a soluble fiber from red seaweed, to create its beverages [9] - Agar-agar helps maintain satiety, reduces appetite, and offers a healthier alternative to traditional sugary drinks [9] - The drinks are low-calorie and free from added sugars, catering to the increasing demand for fiber-rich foods in the U.S. [9] Group 4: Market Demand and Sustainability - There is a growing concern in the U.S. regarding fiber intake, with 95% of Americans not consuming enough fiber, and 64% actively trying to increase their fiber intake [10] - Seaweed is a highly sustainable resource, growing rapidly and capturing more CO2 than terrestrial plants, without the need for freshwater or fertilizers [10] - Aqua Theon employs a zero-waste process, converting by-products from agar extraction into crop fertilizers, producing over 2,800 tons annually [10] Group 5: Future Prospects in the GLP-1 Market - The functional beverage market is expanding rapidly, with OoMee selling over 100,000 bottles within six months and entering over 700 retailers [12] - The market for GLP-1 medications is projected to grow, with the percentage of U.S. adults using such medications increasing from 5.8% in early 2024 to 12.4% by summer 2025 [12] - Companies are adjusting their product offerings to include more protein and fiber in response to the rising popularity of GLP-1 medications [12][13]